APRNs may be authorized to perform additional acts due to training and experience, such as prescribing treatment, devices, and order diagnostic tests pursuant to KRS 314. 011(8). Hormone pellets are compounded implantable pellets for slow release of hormones that lasts four to six months, as such APRN's are unable to prescribe hormone pellets containing testosterone as it is a schedule III-controlled substance and, prescribing of schedule III substances is limited to a 30-day supply without refill. See KRS 314.011(8)(b). Upon review and discussion at the June 19, 2023, meeting it was the decision of the Board that:
The performance of the subcutaneous administration/insertion of hormone replacement therapy with pellet implants is within the scope of advanced practice registered nursing practice for the APRN who is educationally prepared and clinically competent.
Any testosterone supply provided in quantities or duration that are greater than 30 days requires an APRN to obtain a physician's order pursuant to KRS 314.011 (8)(b) for the administration of the hormone replacement therapy pellet implants and the performance of the procedure.